Last updated on August 2019

AURONA - An Open-Label Dose-Exploration Cohort Study Evaluating the Efficacy and Safety of Voclosporin in Achieving Complete or Partial Remission of Proteinuria in Subjects with Focal Segmental Glomerulosclerosis


Brief description of study

Open-label, 24-week, multicenter, exploratory cohort study of VCS

- To assess the efficacy of voclosporin (VCS) in achieving complete or partial remission of proteinuria after 24 weeks of therapy in subjects with focal segmental glomerulosclerosis (FSGS).

- To assess the safety and tolerability of VCS over 24 weeks in subjects with FSGS.

 

Clinical Study Identifier: TX227891

Find a site near you

Start Over

Northwest Louisiana Nephrology, L.L.C.

1800 Buckner Street, Suite C-120 Shreveport, LA USA
  Connect »

Northwest Louisiana Nephrology, L.L.C.

1800 Buckner Street, Suite C-120 Shreveport, Louisiana United States
  Connect »